Literature DB >> 28635396

MicroRNA-34a inhibits tumor invasion and metastasis in osteosarcoma partly by effecting C-IAP2 and Bcl-2.

Jie Wen1,2, Yan-Kun Zhao3, Yan Liu2, Jin-Feng Zhao1.   

Abstract

Osteosarcoma is a common primary malignant bone tumor that occurs mainly in children and adolescents. Recent evidence has demonstrated that miR-34a is involved in the invasion and metastasis of osteosarcoma. This study aims to explore the effect of biological behavior of miR-34a on osteosarcoma. First, we collect osteosarcoma and adjacent specimens, and the relative expression of miR-34a and C-IAP2 messenger RNA was quantitated by real-time polymerase chain reaction. Furthermore, miR-34a stimulant is synthesized and transfected onto osteosarcoma MG-63 cells. The effect of overexpression of miR-34a on osteosarcoma was detected by colony-forming assay, Annexin V-fluorescein isothiocyanate Apoptosis Detection Kit I, Transwell assay, and animal experiment in vivo. Finally, the relative levels of C-IAP2 and Bcl-2 protein were checked by western blot, and the activity of caspase-3 and caspase-9 was tested by spectrophotometry assay. In conclusion, miR-34a was downregulated in osteosarcoma cells. And the expression of C-IAP2 and Bcl-2 protein was drastically inhibited, and the activities of caspase-3 and caspase-9 were significantly increased after transfecting miR-34a onto osteosarcoma MG-63 cells. And the overexpression of miR-34a can inhibit cell invasion and metastasis, promote cell apoptosis, and arrest cells in G0/G1 period. And the animal experiment in vivo demonstrated that the overexpression of miR-34a could significantly inhibit the growth of osteosarcoma in animal skin. Taken together, we indicated that miR-34a can inhibit tumor invasion and metastasis in osteosarcoma, and its mechanism may be partly related to downregulating the expression of C-IAP2 and Bcl-2 protein directly or indirectly.

Entities:  

Keywords:  Bcl-2; C-IAP2; Osteosarcoma; apoptosis; caspase; miR-34a

Mesh:

Substances:

Year:  2017        PMID: 28635396     DOI: 10.1177/1010428317705761

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  13 in total

Review 1.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

Review 2.  Emerging roles of non-coding RNAs in the pathogenesis, diagnosis and prognosis of osteosarcoma.

Authors:  Chongchong Wang; Juehua Jing; Li Cheng
Journal:  Invest New Drugs       Date:  2018-08-06       Impact factor: 3.850

3.  MiR-629-5p promotes the invasion of lung adenocarcinoma via increasing both tumor cell invasion and endothelial cell permeability.

Authors:  Yu Li; Huibiao Zhang; Lei Fan; Jiahui Mou; Yue Yin; Chao Peng; Yuxiang Chen; Henglei Lu; Liting Zhao; Zhouteng Tao; Jing Chen; Yizheng Wang; Xinming Qi; Ruimin Huang; Jin Ren
Journal:  Oncogene       Date:  2020-02-27       Impact factor: 9.867

Review 4.  Mir-34a: a regulatory hub with versatile functions that controls osteosarcoma networks.

Authors:  Zhimin Yang; Tang Liu; Xiaolei Ren; Mei Yang; Chao Tu; Zhihong Li
Journal:  Cell Cycle       Date:  2022-06-14       Impact factor: 5.173

5.  Down-Regulated microRNA-34a Expression as a Prognostic Marker for Poor Osteosarcoma in Mice: A Systematic Review and Meta-Analysis.

Authors:  Wenyi Wang; Shaopu Hu; Junli Chang; Hongfeng Ruan; Wenlan Zhi; Xiaobo Wang; Qi Shi; Yongjun Wang; Yanping Yang
Journal:  J Cancer       Date:  2018-10-18       Impact factor: 4.207

6.  miR-34a targets BCL-2 to suppress the migration and invasion of sinonasal squamous cell carcinoma.

Authors:  Yigang Zhao; Xianzhi Wang
Journal:  Oncol Lett       Date:  2018-09-11       Impact factor: 2.967

7.  MicroR-542-3p can mediate ILK and further inhibit cell proliferation, migration and invasion in osteosarcoma cells.

Authors:  Wei Cai; Yong Xu; Wenshan Zuo; Zhen Su
Journal:  Aging (Albany NY)       Date:  2019-01-11       Impact factor: 5.682

Review 8.  Non-Coding RNAs in Pediatric Solid Tumors.

Authors:  Christopher M Smith; Daniel Catchpoole; Gyorgy Hutvagner
Journal:  Front Genet       Date:  2019-09-20       Impact factor: 4.599

9.  Knockdown of MALAT1 inhibits osteosarcoma progression via regulating the miR‑34a/cyclin D1 axis.

Authors:  Guangchao Duan; Chuanlin Zhang; Changke Xu; Chao Xu; Lei Zhang; Yan Zhang
Journal:  Int J Oncol       Date:  2018-10-19       Impact factor: 5.650

10.  A genetically engineered microRNA-34a prodrug demonstrates anti-tumor activity in a canine model of osteosarcoma.

Authors:  Fernando Alegre; Amanda R Ormonde; Kellie M Snider; Kevin Woolard; Ai-Ming Yu; Luke A Wittenburg
Journal:  PLoS One       Date:  2018-12-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.